RPL10P7

Across TCGA pan-cancer cohorts, RPL10P7 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated RPL10P7 data layer.

The strongest signal is observed in sarcoma (SARC), where higher RPL10P7 RNA is associated with better overall survival. In most high-consensus cancer types, elevated RPL10P7 expression acts as an unfavorable survival marker, although some lineages such as SARC and CESC show a favorable association.

SARC, CESC, and LUSC are the cancer types where RPL10P7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SARC	OS	Tertile	All	0.847	0.629	<.001	36	view →
CESC	DFS	Quartile	All	0.872	0.706	.002	34	view →
LUSC	OS	Tertile	All	0.480	0.307	.002	29	view →
READ	DFS	Tertile	III,IV	0.765	0.379	.001	29	view →
STAD	OS	Median	III,IV	0.206	0.444	.008	29	view →
UVM	DFS	Quartile	All	0.733	0.351	.008	23	view →
COAD	OS	Quartile	All	0.962	0.752	.002	20	view →
LGG	OS	Quartile	All	0.420	0.928	.003	18	view →
BRCA	DFS	Median	III,IV	0.855	0.735	.006	15	view →
SKCM	DFS	Median	All	0.246	0.169	.009	12	view →
KIRP	OS	Median	III,IV	0.208	0.751	.013	12	view →
LIHC	OS	Tertile	II,III,IV	0.464	0.732	.006	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

RPL10P7–SARC (OS)

Open the SARC breakdown →